TransMedics Group Inc Asset Resilience Ratio
TransMedics Group Inc asset resilience ratio. TransMedics Group Inc (TMDX) has an Asset Resilience Ratio of 0.00% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See TransMedics Group Inc (TMDX) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of TransMedics Group Inc (2006–2022)
Asset resilience ratio of TransMedics Group Inc from 2006 to 2022. This chart shows how TransMedics Group Inc's Asset Resilience Ratio has changed over time. Read TransMedics Group Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down TransMedics Group Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see TransMedics Group Inc balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: TransMedics Group Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
TransMedics Group Inc Industry Peers by Asset Resilience Ratio
Compare TransMedics Group Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
TransMedics Group Inc Asset Resilience Ratio by Year (2006–2022)
TransMedics Group Inc asset resilience ratio by year from 2006 to 2022. The table below shows the annual Asset Resilience Ratio data for TransMedics Group Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.00% | $0.00 | $277.15 Million | -- |
| 2021-12-31 | 49.57% | $66.87 Million | $134.89 Million | -16.90pp |
| 2020-12-31 | 66.48% | $101.06 Million | $152.03 Million | +8.93pp |
| 2019-12-31 | 57.55% | $60.60 Million | $105.30 Million | -- |
| 2018-12-31 | 0.00% | $0.00 | $42.16 Million | -- |
| 2017-12-31 | 34.40% | $12.73 Million | $37.00 Million | -31.01pp |
| 2016-12-31 | 65.40% | $38.00 Million | $58.10 Million | +46.61pp |
| 2006-12-31 | 18.79% | $2.80 Million | $14.90 Million | -- |
About TransMedics Group Inc
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic con… Read more